CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
0.163
-0.003 (-2.01%)
Mar 28, 2024, 3:59 PM EDT - Market closed

CytoDyn Cash Flow Statement

Millions USD. Fiscal year is Jun - May.
Year 2023202220212020201920182017201620152014 2013 - 2004
Net Income
-79.82-288.16-174.02-141.78-56.19-48.46-25.76-25.7-25.93-12.43
Upgrade
Depreciation & Amortization
0.180.781.82.031.250.360.370.360.360.35
Upgrade
Share-Based Compensation
4.286.2410.436.553.391.291.22.350.630.93
Upgrade
Other Operating Activities
50.26203.4244.2264.41.0916.91-2.54-1.8212.923.76
Upgrade
Operating Cash Flow
-25.11-77.72-117.57-68.8-50.47-29.9-26.73-24.81-12.02-7.39
Upgrade
Capital Expenditures
00-0.12-0.04-0.050-0.01-0.01-0.02-0.02
Upgrade
Investing Cash Flow
00-0.12-0.04-0.050-0.01-0.01-0.02-0.02
Upgrade
Dividends Paid
00-0.24-0.01000000
Upgrade
Common Stock Issued
25.7941.2112.6738.2725.2219.1337.57013.64
Upgrade
Share Repurchases
00138.33-0.01000000
Upgrade
Other Financing Activities
4.146.82274.926714.484.13-0.26-4.168.2-1.95
Upgrade
Financing Cash Flow
29.9348.01137.3579.6752.7529.3518.8833.418.211.69
Upgrade
Net Cash Flow
4.82-29.7119.6510.832.24-0.54-7.878.59-3.844.28
Upgrade
Free Cash Flow
-25.11-77.72-117.7-68.84-50.51-29.9-26.74-24.82-12.04-7.41
Upgrade
Free Cash Flow Margin
--29219.17%--------
Upgrade
Free Cash Flow Per Share
-0.03-0.11-0.20-0.16-0.19-0.17-0.19-0.26-0.21-0.16
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.